Selank 10 mg Certificate of Analysis Batch APL-SEL10-2608-03

Selank 10 mg from batch APL-SEL10-2608-03 was analysed on 19 August 2026 and measured 99.45% purity by HPLC / Mass Spectrometry, passing all 5 release tests.

Purity: 99.45%
Result: All 5 tests passed
Tested: 19 August 2026
Method: HPLC / Mass Spectrometry
Net content: 10.11 mg

Independent verification

Selank 10 mg is independently verified by Ozcanium Analytics, an independent Australian laboratory, at 99.17% purity by UPLC-MS/MS, analysed 28 August 2026 on lot APL-SEL5-2608-01, net content 4.90 mg, verification code OZ-HPLCMS-TS02; bacterial endotoxin below 15.0 EU per vial by kinetic chromogenic LAL, analysed 28 August 2026, verification code OZ-ENDOTX-TPA5.

Issued by Ozcanium Analytics. Covers every vial size of this compound; each report opens as the laboratory issued it.

Third-Party Purity COA (PDF, opens in a new tab)99.17% purity by UPLC-MS/MS · net content 4.90 mg Analysed 28 August 2026 Verification code OZ-HPLCMS-TS02
Third-Party Endotoxin Test (PDF, opens in a new tab)Bacterial endotoxin below 15.0 EU per vial by kinetic chromogenic LAL Analysed 28 August 2026 Verification code OZ-ENDOTX-TPA5

Enter a code in the Ozcanium Analytics verification portal (opens in a new tab) to confirm the report against their own records.

The certificate as issued is reproduced below — pinch to zoom on a phone, or use Print / Save as PDF for a full-size copy.

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 1 of 2

Certificate of Analysis Selank 10 mg Batch APL-SEL10-2608-03

Compound: Selank
Lot Number: APL-SEL10-2608-03
Analysis Date: 19 August 2026
Method: HPLC / Mass Spectrometry
Purity: 99.45%
Net Content: 10.11 mg

CAS Number: 129954-34-3
Formula: C33H57N11O9
Molecular Weight: 751.9 g/mol
Form: Lyophilised Powder
Manufactured: August 2026
Issued: 20 August 2026
Document ID: APL-COA-SEL10-2608-03
Verification Code: Batch traceable

SequenceThr-Lys-Pro-Arg-Pro-Gly-Pro

High Performance Liquid Chromatography (HPLC-UV) Chromatogram

Main peak integrated at 99.45% of total area; no single impurity peak exceeds 0.21%.

Peak List

Peaks detected: 5

#	Time (min)	Area	% Area	Identification
1	1.860	10,080	0.140	—
2	2.140	7,160,400	99.450	Selank
3	2.330	15,120	0.210	—
4	2.760	9,360	0.130	—
5	4.080	5,040	0.070	—

Analytical Results

Test	Specification	Result	Status
Appearance	White/Off-White Lyophilised Powder	Conforms	PASS
Identity (MS)	Confirmed	Confirmed	PASS
Purity (HPLC)	≥98.0%	99.45%	PASS
Peptide Content	95–105%	97.9%	PASS
Endotoxins	<0.5 EU/mg	<0.15 EU/mg	PASS

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 2 of 2

Selank 10 mg

CAS Number: 129954-34-3

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 19 August 2026

Monitored (m/z)	Detected (m/z)	Relative Intensity
377	376.96	1.2
753	752.91	2.7

Detection assignment: Selank

Collected Mass Spectrum

Intensity ×10⁷

Verification Protocol

Identity confirmed by mass spectrometry against the expected ion channels.
Purity measured by HPLC as peak area against all integrated impurity peaks.
Batch traceability: this document reports the lot number printed on the vial.
Analysis performed in-house by Australian Peptide Labs.

Supplied for laboratory research use only. Not a therapeutic good; not for human or veterinary use.

View Selank in the catalogue How to read this certificate